What You Need to Know About HCA Healthcare, Inc.'s Q3 Earnings
HCA Healthcare, Inc.'s fiscal Q3 earnings report was released on Friday, July 24. Let's dive in to see if (HCA) missed or beat analyst's expectations.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Commentary & Analysis
Which Is a Better Investment, HCA Healthcare, Inc. or Henry Schein, Inc. Stock?
Learn more about whether HCA Healthcare, Inc. or Henry Schein, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Rosalio Madrigal
Why HCA Healthcare, Inc.’s (HCA) Stock Is Down 5.86%
As of Tuesday, July 14, HCA Healthcare, Inc.’s HCA share price has dipped by 5.86%, which has investors questioning if this is right time to buy.Michael Rose
3 Undervalued Health Care Providers & Services Stocks for Friday, July 03
Discover the top 3 undervalued Health Care Providers & Services stocks for Friday, July 03 based on AAII’s Stock Grades.Rosalio Madrigal
Why HCA Healthcare, Inc.’s (HCA) Stock Is Up 5.21%
As of Thursday, July 02, HCA Healthcare, Inc.’s HCA share price has surged by 5.21%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | HCA | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $85,689.1 | $1,875.0 | 96% |
|
| Shares Out (Mil) | 222.8 | 77.1 | 79% |
|
| Institutional Ownership | 97.7% | 88.9% | 75% |
|
| Float (Mil) | 144.2 | 50.3 | 69% |
|
| Beta | 1.13 | 0.86 | 67% |
|
| Avg Daily Volume (000s) | 1,742 | 466 | 80% |
|
| Price Change (52-week) |
14.9% | 78.5% | 58% |
|
| Growth | HCA | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 8.0% | 10.9% | 50% |
|
| Net Income (5yr) | 12.6% | (1.1%) | 59% |
|
| EPS (5yr) | 21.0% | 3.0% | 69 |
|
| Dividends (5yr) | 46.3% | 0.0% | 94% |
|
| Cash Flow (5yr) | (25.3%) | (18.2%) | 25% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 19 | 22 | 22 | |
| Current EPS | $6.777 | $29.559 | $32.181 | |
| Month Ago EPS | $7.273 | $30.192 | $33.094 | |
| # Rev Up | 2 | 0 | 8 | |
| # Rev Down | 1 | 1 | 11 | |
| Three Months Ago EPS | $7.298 | $30.194 | $33.145 | |
| Year/Year Chg | (11.1%) | 4.3% | 24.0% | |
| Financials | HCA | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $78,013 | $1,464 | 98% |
|
| Net Income (TTM) (Mil) | $6,840 | $15 | 98% |
|
| EPS (TTM) | $30.276 | $0.300 | 99% |
|
| Operating Cash Flow (TTM) (Mil) | $11,124 | $138 | 98% |
|
| Net Cash Flow (TTM) (Mil) | $74 | $7 | 75% |
|
| Long-Term Debt (Q1) (Mil) | $45,288 | $323 | 98% |
|
| Enterprise Value (Q1) (Mil) | $142,227 | $2,130 | 98% |
|
| Valuation | HCA | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.90 | na |
|
| P/E | 13.2 | 26.8 | 29% |
|
| Dividend Yield | 0.8% | 0.0% | 65% |
|
| PEG (5yr hist) | 0.6 | 1.1 | 31% |
|
| Ratios | HCA | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 42.6% | 27.6% | 53% |
|
| Net Margin | 8.8% | 1.1% | 60% |
|
| ROA | 11.1% | 1.8% | 89% |
|
| ROE | (124.0%) | 6.9% | 8% |
|
| Liabilities to Assets | 105.1% | 60.0% | 95% |
|
| F-Score | 8 | 5 | 94% |
|
Passing Stock Screens
As of 7/30/2026, from a list of 60 stock screening strategies,
GURU STRATEGY
Neff Screen
Factors: Value, Growth
An approach using a stringent contrarian viewpoint—finding undervalued, out-of-favor stocks in the bargain basement that have an optimistic future.
| Performance Since Inception: | 14.4% |
| +/- S&P 500: | +6.9 |
